George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Cisco (CSCO): Ready to break out?


Bookmark and Share

 "We’re seeing a very bullish technical pattern form in the daily stock chart at Oracle (NASDAQ: ORCL)," says Richard Schmidt. Here's the advisor's review from the Stellar Stock Alert.

"The stock is definitely in an uptrend. But since May, the stock has been in an upward trending trading range.

Advertisement
Banner

"Now what is that? It’s simply a trading range where the lows of the range are increasing. Let me explain.

"The stock has been trading between $19.47 on the low side and $22.89 on the high side for over six months. Every time the stock corrects, it stops just a little bit higher than the last time it corrected.

"In June, it set the low of the range at $19.47. The next time that low was tested, it stopped at $20.10 and again at $20.65. Each time, the test stopped a little higher.

"Higher lows are very bullish. The same is true on the high end of the trading range – but to a lesser degree. But it’s still very bullish.

"It means the stock is gaining strength to breakthrough to the upside. So much so, that it’s expanding the range upward each time it moves up. The stock is also above both moving averages, which is also bullish.

"The stock is going to need as much strength as it can get to break through the $24 level. So this is great news on the technical side. Add this to the stock's flag formation, and you have a technical recipe for a massive move to the upside.

"Now we just have to wait and watch it happen. It could happen any time. ORCL is a strong buy right now. Buy it before it breaks out in a big way." 


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...